CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients

Stopped early

Conditions studied: Transplantation, Kidney, Cardiovascular Abnormalities, Cardiovascular Diseases

In brief

We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of these cells in patients who have had a kidney transplant and predict their risk of developing cardiovascular disease.

Key facts

Study ID

NCT00365833

Run by

University of Florida

People needed

8

Starts

2006-07-01

Expected to finish

2007-02-01

Last updated by the study team

2011-09-30

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• kidney transplant recipients
• kidney/pancreas transplant recipients
• age 18-80

You may not qualify if…

• inability to return for follow-up visits
• multiple organ transplant other than listed above

Where it is running

• University of Florida — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.